ATP III

ATP III

Adult Treatment Panel III. A brief overview of the National Cholesterol Education Program’s (NCEP) updated clinical guidelines for detecting, evaluating, and treating high cholesterol in adults.
Summary ATP III recommends that all adults above age 20 should get a fasting baseline lipoprotein profile every 5 years.
Rationale The profile is a parameter which, like diabetes, hypertension and other “traditional” heart disease risk factors, serves as a basis for determining the intensity of risk-reducing interventions.
Mentioned in ?
References in periodicals archive ?
The statement also clarifies some issues, however, and provides some minor modifications to the ATP III definition of the metabolic syndrome--a term that denotes the clustering of interrelated metabolic risk factors for atherosclerotic cardiovascular disease.
De acuerdo con las actuales guias del Programa Nacional de Educacion en Colesterol de Estados Unidos, denominadas ATP III (Adult Treatment Panel III), el nivel deseable de colesterol total es menor a 200 mg/dl (miligramos por decilitro), mientras que el colesterol LDL o malo debe estar por debajo de los 100 mg/dl y el colesterol HDL o bueno por arriba de 45 mg/dl.
We recommend that HIV-infected adults undergo evaluation and treatment on the basis of NCEP ATP III guidelines [National Cholesterol Education Project--Adult Treatment Panel III] for dyslipidemia, with particular attention to potential drug interactions with antiretroviral agents and maintenance of virologic control of HIV infection.
The Vertical Auto Profile (VAP) technology reveals residual cardiometabolic risk as recommended in the NCEP ATP III, ADA/ACC Joint Consensus and AACE guidelines.
Lipid profile: According to NCEP and ATP III, LDL-C target for diabetic patients is < 100 mg/dL, high-density lipoprotein (HDL-C) target [greater than or equal to] 40 mg/dL, triglycerides target <150 mg/dL, and total cholesterol target <200 mg/dL.
MS was diagnosed if three or more criteria of the National Cholesterol Education Program's Adult Treatment Panel III (ATP-III) were present, as given below:[8} NCEP: ATP III 2001.
Conclusions: Higher serum GGT within its reference range was significantly correlated with a 10-year CHD risk prediction estimation using NCEP ATP III in Korean men.
Metabolic syndrome in urban Asian Indian adults: a population study usingmodified ATP III criteria.
Of note, the majority of the difference between the estimates based on the ATP III guidelines and the ACCAHA guidelines is due to the lower threshold for consideration of treatment, which was derived directly from the evidence base from newer primary-prevention randomized clinical trials, he said.
The four sets of clinical practice guidelines were initially commissioned by the National Heart, Lung, and Blood Institute in 2008, and were then transitioned to the AHA and ACC earlier this year, 12 years after ATP III was released.
1a] Nonstandard abbreviations: CVD, cardiovascular disease; LDL-C, LDL cholesterol; NCEP ATP III, National Cholesterol Education Program Adult Treatment Panel III; apoB, apolipoprotein B; NMR, nuclear magnetic resonance; LDL-P, LDL particle number determined by NMR spectroscopy; HDL Lab, Health Diagnostics Laboratory.